| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/15/2001 | CA2383798A1 Pulmonary delivery for bioconjugation |
| 03/15/2001 | CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2383213A1 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/14/2001 | EP1083224A2 Apoptin-associating protein |
| 03/14/2001 | EP1083172A1 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 03/14/2001 | EP1082962A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZO C ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-$g(k)B |
| 03/14/2001 | EP1082456A1 Antisense modulation of cd40 expression |
| 03/14/2001 | EP1082432A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 03/14/2001 | EP1082426A2 Human socs proteins |
| 03/14/2001 | EP1082346A1 Specific binding proteins for treating canine allergy |
| 03/14/2001 | EP1082340A1 Peptide vaccine for canine allergy |
| 03/14/2001 | EP1082334A1 Alg-2lp, alg-2 like molecules and uses therefor |
| 03/14/2001 | EP1082320A1 Novel substituted imidazole compounds |
| 03/14/2001 | EP1082310A1 Methods of identifying and using hla binding compounds as hla-agonists and antagonists |
| 03/14/2001 | EP1082305A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/14/2001 | EP1082302A1 A vla-4 inhibitor: omepupa-v |
| 03/14/2001 | EP1082298A2 1$g(a)-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF |
| 03/14/2001 | EP1082137A1 REVERSAL OF PROINFLAMMATORY RESPONSE BY LIGATING THE MACROPHAGE Fc$g(g)RI RECEPTOR |
| 03/14/2001 | EP1082135A1 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants |
| 03/14/2001 | EP1082131A2 Immunoregulator |
| 03/14/2001 | EP1082130A1 Use of cyclosporins in the treatment of inflammatory autoimmune diseases |
| 03/14/2001 | EP1082120A1 PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE |
| 03/14/2001 | EP1082119A1 Microemulsion preconcentrates containing a piperidine substance p antagonist |
| 03/14/2001 | EP1082117A1 A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer |
| 03/14/2001 | EP0831817B1 Antigen-processing cell-targeted conjugates comprising a polyamino acid backbone and a non-steroidal anti-inflammatory agent |
| 03/14/2001 | CN1287555A N-oxides of heterocyclic compounds with TNF and PDE IV inhibiting activity |
| 03/14/2001 | CN1287493A Formulation of nucleic acids and acemannan |
| 03/14/2001 | CN1063176C Chromone derivative |
| 03/13/2001 | US6201132 Inhibitors of membrane-bound serine protease; aminoacyl compounds |
| 03/13/2001 | US6201124 Process for production of piperidine derivatives |
| 03/13/2001 | US6201115 Amplifying sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications |
| 03/13/2001 | US6201105 Amino acid sequence; treatment of septic shock and cachexia; diagnosis |
| 03/13/2001 | US6201024 Effective p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disorders |
| 03/13/2001 | US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction |
| 03/13/2001 | US6201005 Method for inhibiting lymphokine production |
| 03/13/2001 | US6200993 Heterosubstituted pyridine derivatives as PDE4 inhibitors |
| 03/13/2001 | US6200985 Rapamycin derivatives |
| 03/13/2001 | US6200978 For preventing or treating inflammatory diseases such as arthritis, psoriasis, asthma, or inflammatory bowel disease, disorders of respiratory function, gastrointestinal disorders such as functional bowel disease, as analgesics |
| 03/13/2001 | US6200798 Defective recombinant adenoviruses with inactivated IVa2 gene |
| 03/13/2001 | US6200787 Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae |
| 03/13/2001 | US6200780 Human interferon-ε(IFN-ε), a type I interferon |
| 03/13/2001 | US6200779 Nucleotide sequences which code protein associated with bacterial infection; for prevent of infections and associated defects |
| 03/13/2001 | US6200774 Compounds |
| 03/13/2001 | US6200599 Ortho ester lipids |
| 03/13/2001 | US6200598 Active materials entrapped within liposome interior |
| 03/13/2001 | US6200592 Immine response modifier compounds for treatment of TH2 mediated and related diseases |
| 03/13/2001 | US6200567 An antibody that binds to the common beta c chain of the receptor for gm-csf, il-3 and il-5 |
| 03/13/2001 | CA2146238C Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 03/13/2001 | CA2119149C Drug, particularly an immunomodulator, containing non-fructifying, non-photosynthetic filamentous bacteria envelopes or fractions thereof, and preparation thereof |
| 03/11/2001 | CA2486805A1 A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate |
| 03/08/2001 | WO2001016603A2 Analysis and treatment of body weight and eating disorders |
| 03/08/2001 | WO2001016347A1 The hematopoietic, myeloprotecting, antitumor immune cells generating and radiosensitizing polysaccharide isolated from panax ginseng |
| 03/08/2001 | WO2001016345A2 Sequence-specific dna recombination in eukaryotic cells |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016314A1 Iren protein, its preparation and use |
| 03/08/2001 | WO2001016301A1 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 03/08/2001 | WO2001016297A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | WO2001016296A2 Use of cytokines, cells, and mitogens to inhibit graft versus host disease |
| 03/08/2001 | WO2001016293A2 Dna encoding the human serine protease t |
| 03/08/2001 | WO2001016178A1 MATERIALS AND METHODS FOR INHIBITION OF IgE PRODUCTION |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016165A2 Apoptin-associating protein |
| 03/08/2001 | WO2001016164A2 Treatment of allergic rhinitis |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016145A1 Immunopotentiating compositions |
| 03/08/2001 | WO2001016137A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 03/08/2001 | WO2001016135A2 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | WO2001016134A1 Selective antagonists of a2b adenosine receptors |
| 03/08/2001 | WO2001016106A1 Benzamide formulation with histone deacetylase inhibitor activity |
| 03/08/2001 | WO2001016099A1 VITAMIN D DERIVATIVES HAVING SUBSTITUENTS AT THE 2α-POSITION |
| 03/08/2001 | WO2001016097A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/08/2001 | WO2001016093A1 SUBSTITUTED α-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF |
| 03/08/2001 | WO2001016091A1 Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof |
| 03/08/2001 | WO2001015745A1 Method and formula for tumor remission and suppression of cancer |
| 03/08/2001 | WO2001015733A2 Compositions for treating autoimmune disease containing a compounds which regulates icam-lfa-1 interaction and a compounds which regulates cd40-cd40 ligand interaction |
| 03/08/2001 | WO2001015732A1 Remedies for immunological diseases |
| 03/08/2001 | WO2001015728A1 Method for activating cytotoxic t-lymphocytes (ctls) in vivo : composition comprising antibody anti cd40 (or cd40l or cd40 binding protein) and an antigen |
| 03/08/2001 | WO2001015727A2 Compositions of immunostimulatory polymers and saponin adjuvants and uses thereof |
| 03/08/2001 | WO2001015726A2 Compositions for stimulating cytokine secretion and inducing an immune response |
| 03/08/2001 | WO2001015710A2 A method of treatment of human immunodeficiency diseases |
| 03/08/2001 | WO2001015707A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 03/08/2001 | WO2001015694A1 Extended duration light activated cancer therapy |
| 03/08/2001 | WO2001015683A1 Delayed-action form of administration containing tramadol saccharinate |
| 03/08/2001 | WO2001015682A1 Pharmaceutical tramadol salts |
| 03/08/2001 | WO2001015681A1 Oral pharmaceutical forms of administration with a delayed action |
| 03/08/2001 | WO2001015668A1 Controlled release pellet formulation |
| 03/08/2001 | WO2001015667A1 Oral dosage forms |
| 03/08/2001 | WO2001015553A1 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 03/08/2001 | WO2000069458A3 Adjuvant combinations for immunization composition and vaccines |
| 03/08/2001 | WO2000062767A3 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion |
| 03/08/2001 | WO2000059506A8 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 03/08/2001 | WO2000059448A3 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 03/08/2001 | WO2000049137A3 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 03/08/2001 | WO2000026246A9 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 03/08/2001 | WO2000020447A8 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |